Thomas A. West

Thomas A. West, listed as chief executive, has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Inogen Inc, Intersect ENT, Inc. and SI-BONE, Inc. Over a trading history stretching from 23 July 2021 to 28 July 2026, the count stands at 11 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The record was last updated on 30 July 2026 with a share grant in Ceribell, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.